ArticleJAC-antimicrobial resistance2025

HIV-1 cross-resistance to second-generation non-nucleoside reverse transcriptase inhibitors among individuals failing antiretroviral therapy in Cameroon: implications for the use of long-acting treatment regimens in low- and middle-income countries.

Davy-Hyacinthe Gouissi Anguechia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.